Local News Matters on MSN2h
Bay City Books: New books from Bay Area and Northern California authors – April 2025These are among the new titles released by Bay Area and Northern California writers, listed in alphabetical order by author ...
Vicki DeArmon launched Foghorn Press and Sibylline Press, and has now written an “almost true” memoir of San Francisco’s ...
Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are ...
As the founder of a small publishing company in 1980s San Francisco, Vicki DeArmon recruited authors, negotiated contracts and persuaded stores to stock her books. Almost always, she said recently, ...
Foghorn Therapeutics Inc. announced continued enrollment in its Phase 1 trial for FHD-909, a first-in-class oral selective SMARCA2 inhibitor targeting SMARCA4 mutated cancers, particularly non ...
March 06, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting ...
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have earned a consensus rating of “Buy” from the six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback